Skip to main content
Log in

Antiarrhythmic properties of Dimebon

  • Pharmacology and Toxicology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

The H1-receptor blocker Dimebon is shown to exhibit pronounced antiarrhythmic properties. Its activity and therapeutic action range (toxic/therapeutic ratio) exceed those of quinidine, ethmosine, isoptin, and bonnecor in several animal models of cardiac arrhythmia. The mechanism of its antiarrhythmic action is probably associated with blockade of sodium and particularly calcium channels, prolongation of the effective refractory period, and slowing of impulse traffic in the conduction system of the heart. Dimebon may be recommended for submission to clinical trials as an antiarrhythmic agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. M. Ammar and A. N. Kudrin,Farmakol. Toksikol.,32, No 5, 566–570 (1969).

    PubMed  CAS  Google Scholar 

  2. M. L. Belen'kii,Quantifying Pharmacological Effects: Selected Topics [in Russian], Leningrad (1963).

  3. A. I. Bryskin, I. K. Sokolov, E. E. Belen'kii, and N. G. Glazova,Farmakol. Toksikol.,37, No 3, 303–306 (1974).

    Google Scholar 

  4. A. K. Grenader,Antiarrhythmics as Blockers of Ion Channels. Mechanisms of Action and Structure [in Russian], Pushchino (1987).

  5. T. I. Il'yuchenok and I. A. Matveeva,Dimebon: a New Antihistamine, in:Ekspress-informatsiya. Novye Lekarstvennye Preparaty [Up-to-Date Information. New Drugs], No 4, 12–16 (1989).

  6. M. V. L'vov,Zh. Eksp. Klin. Med.,13, No 6, 24–28 (1973).

    PubMed  Google Scholar 

  7. N. A. Mokhort and N. N. Seredinskaya,Farmakol. Toksikol.,50, No 6, 55–58 (1987).

    PubMed  CAS  Google Scholar 

  8. V. B. Prozorovskii and M. P. Prozorovskaya,Farmakol. Toksikol.,43, No 6, 733–735 (1980).

    PubMed  CAS  Google Scholar 

  9. V. A. Shatalov and N. V. Dmitrieva,Khim.-Farm. Zh., No 3, 322–326 (1986).

    Google Scholar 

  10. G. M. Yakovlev, V. I. Skorobogatov, A. S. Svistov, and M. I. Mironova,Farmakol. Toksikol.,54, No 5, 25–27 (1991).

    CAS  Google Scholar 

  11. G. A. Alles and C. H. Ellis,J. Pharmacol. Exp. Ther.,94, 416 (1948).

    CAS  Google Scholar 

  12. A. K. Filippov and I. Porotikov,Gen. Physiol. Biophys.,2, 95–106 (1983).

    Google Scholar 

  13. A. S. Harris,Circulation,6, 1318 (1950).

    Google Scholar 

  14. M. R. Malinow, F. F. Battle, and B. Malamud,Amer. J. Physiol.,175, No 1, 8–10 (1953).

    PubMed  CAS  Google Scholar 

  15. A. Rosenblueth and G. Ramos,Amer. Heart J.,5, 677 (1947).

    Article  Google Scholar 

  16. M. Winbury and M. L. Hemmer,Circulat. Res.,111, No 5, 474 (1955).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 119, No 4, pp. 375–377, April, 1995

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galenko-Yaroshevskii, P.A., Chekanova, O.A., Skibitskii, V.V. et al. Antiarrhythmic properties of Dimebon. Bull Exp Biol Med 119, 362–364 (1995). https://doi.org/10.1007/BF02445893

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02445893

Key Words

Navigation